Commercial Lidocaine Patch as a Treatment for Ear-ringing

• Status: Completed
• Trial end date: 2015-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this investigation is to evaluate if topically applied lidocaine, in the form of lidocaine patches, reduces the burden of chronic subjective tinnitus in a consistent and measurable way.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of California, Davis
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• 18 years of age

• History of chronic subjective tinnitus that cannot be attributed to vascular, neurologic, neoplastic or traumatic causes

• Capable of self-applying the lidocaine patches

Exclusion Criteria:

• History of heart disease

• History of irregular heartbeat

• Prior MI

• Previous exposure to lidocaine as a treatment for tinnitus

• An allergy to adhesives

• Allergy to lidocaine.

• Taking medications, herbal remedies and supplements that may interact with lidocaine, including but not limited to antivirals, benzodiazepines, and St. John's Wart

• Known liver disease

• Known kidney disease

• Adults who do not speak English,

• Adults who cannot consent for him or herself

• Women who are pregnant,

• Women who intend to become pregnant

• Nursing mothers

• Prisoners